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Abstract
Babies with gastroschisis have high morbidity, which is associated with inflammatory bowel injury caused by exposure to 
amniotic fluid. The objective of this study was to identify components of the inflammatory response in the intestine and liver in 
an experimental model of gastroschisis in rats. The model was surgically created at 18.5 days of gestation. The fetuses were 
exposed through a hysterotomy and an incision at the right of the umbilicus was made, exposing the fetal bowel. Then, the 
fetus was placed back into the uterus until term. The bowel in this model had macro- and microscopic characteristics similar 
to those observed in gastroschisis. The study was conducted on three groups of 20 fetuses each: gastroschisis, control, and 
sham fetuses. Fetal body, intestine and liver weights and intestine length were measured. IL-1β, IL-6, IL-10, TNF-α, IFN-γ and 
NF-kappaB levels were assessed by ELISA. Data were analyzed statistically by ANOVA followed by the Tukey post-test. Gas-
troschisis fetuses had a decreased intestine length (means ± SD, 125 ± 25 vs 216 ± 13.9; P < 0.005) and increased intestine 
weight (0.29 ± 0.05 vs 0.24 ± 0.04; P < 0.005). Intestine length correlated with liver weight only in gastroschisis fetuses (Pear-
son’s correlation coefficient, r = 0.518, P = 0.019). There were no significant differences in the concentrations of IL-1β, TNF-α 
or IFN-γ in the intestine, whereas the concentration of NF-kappaB was increased in both the intestine and liver of fetuses with 
gastroschisis. These results show that the inflammatory response in the liver and intestine of the rat model of gastroschisis is 
accompanied by an increase in the amount of NF-kappaB in the intestine and liver. 
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Gastroschisis affects 1.62/10,000 liveborns (1) and this 
incidence is increasing worldwide (2). Despite a low mortal-
ity, these patients have a high morbidity rate associated with 
dysmotility, intestinal atresia and necrotizing enterocolitis 
(3). These anatomical and functional changes have been 
attributed to the exposure of the intestine to amniotic fluid 
(4). The intestine presents loss of contractility, decreased 
enzymatic activity of the villi and alterations in collagen 
synthesis in the submucosal region (5). These histological 
(6,7) and biochemical (8,9) abnormalities resulting from 
inflammation have been demonstrated in both experimental 
models and humans.
Investigation of human amniotic fluid in gastroschisis has 
shown increased cellularity and increased levels of total pro-
tein, ferritin, interleukin (IL)-6, and IL-8 (10). However, the spe-
cific inflammatory pathways that are activated in the chronic 
inflammation of the intestine observed in gastroschisis are 
not known. Among the proinflammatory cytokines involved 
in intestinal lesions are tumor necrosis factor-α (TNF-α), IL-6 
and interferon-gamma (IFN-γ) (11). All of these factors may 
be stimulated by the activation of hepatic NF-kappa. When 
the cells are stimulated, NF-kappaB is released and migrates 
to the nucleus, where it interacts with a specific sequence in 
the region that promotes target genes (12).
The hepatic Kupffer cells (hepatic histiocytes) are the 
cells that produce NF-kappaB the most, followed by the 
hepatocytes themselves (12). The regulation of inflammation 
and necrosis involves an intricate balance between pro- and 
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anti-inflammatory cytokines. Among the genes activated 
by NF-kappaB are proinflammatory genes and codifiers of 
cytotoxic cytokines (13). NF-kappaB also participates in the 
prevention of apoptosis during hepatic regeneration (14).
We hypothesized that the intestinal inflammatory pro-
cess triggered by the amniotic fluid in gastroschisis may 
be sufficient to activate specific pathways of the inflam-
matory response not only in the intestine, but also in the 
liver. For this purpose, we assessed the levels of cytokines 
in the liver and intestine in an experimental rat model of 
gastroschisis.
Material and Methods
The experimental protocol was approved by the Ani-
mal Research Committee of the University of Campinas 
(UNICAMP) and followed the Guidelines for the Care and 
Use of Laboratory Animals (internal #281-1).
Model
Female Sprague-Dawley rats were mated and checked 
for introital plugging. The day of plugging was defined as 
gestational day 0 for time dating (term = 22 days). The 
pregnant rats were kept in individual cages and acclimated 
to dark/light cycling conditions.
On day 18.5 of gestation, the animals underwent surgery 
in order to create experimental gastroschisis. The procedure 
was performed under anesthesia with ketamine (50 mg/mL; 
Pfizer do Brasil Ltda., Brazil) in combination with xylazine 
(10 mg/mL; Rompun®, Bayer do Brasil Ltda., Brazil) ad-
ministered in the right posterior limb. The abdominal ventral 
region was shaven with an electric razor (Sunbeam®, USA) 
and cleaned with chlorohexidine soap. The abdominal wall 
was opened through a median longitudinal incision and the 
uterus was exposed. Fetuses were operated upon according 
to the technique of Correia-Pinto et al. (15). For creation of 
gastroschisis, a purse-string suture was placed in the uterine 
wall near the lower body of the fetus. The uterus and the 
amniotic cavity was then opened and the lower body of the 
fetus was carefully exposed through the incision. A 3-mm 
incision was then made on the abdominal wall of the fetus 
to the right of the umbilicus, through which the fetal bowel 
was exposed. We modified the technique of Correia-Pinto 
et al. (15) with a maneuver that facilitated the abdominal 
opening procedure. We exposed both legs of the fetus and 
made the incision with a direct view of the umbilical cord. 
This position permitted a very safe and controlled incision 
without damage to the umbilical vasculature. After exposure 
of the fetal bowel, the lower body of the fetus was carefully 
placed back into the amniotic cavity and the uterus and the 
purse-string suture of the uterine wall was closed. The first 
and last fetuses in each uterine horn were not used. The 
remaining fetuses were then sequentially used as follows: 
the second fetus, the first to be operated upon, was the fetus 
with gastroschisis, the subsequent one was the control fetus, 
the next one was the sham fetus, and so on. Control fetuses 
were left undisturbed and sham fetuses were exposed to 
hysterectomy and manipulated but without abdominal wall 
opening. After gastroschisis and sham operations were 
made in both uterine horns, the uterus was placed back in 
the abdominal cavity of the mother and the abdominal wall 
was closed in two layers. A total of 24 fetuses were included 
in each group - gastroschisis, control and sham.
Fetuses were harvested by cesarean section on day 21.5 
of gestation. Fetuses were weighed and then sacrificed with 
a lethal dose of anesthetic. The intestinal tract was removed 
from pylorus to rectum and its length was measured.
The three groups of fetuses were compared for body 
weight (BW), liver weight (LW), intestine weight (IW), in-
testine length (IL), liver weight/body weight ratio (LW/BW), 
intestine weight/body weight ratio (IW/BW) and intestine 
weight/intestine length ratio (IW/IL).
Immunoprecipitation
Liver and intestine fragments were homogenized in 
immunoprecipitation buffer containing 1% Triton X-100, 
100 mM Tris, pH 7.4, 100 mM sodium pyrophosphate, 100 
mM sodium fluoride, 10 mM EDTA, 10 mM sodium ortho-
vanadate, 2 mM PMSF, and 0.1 mg/mL aprotinin at 4°C. 
The homogenized sample was then centrifuged at 11,000 
rpm for 20 min. Supernatant protein concentration was 
measured by the method of Lowry and immunoprecipitation 
was achieved with a specific anti-NF-kappaB antibody in 
a 1:10,000 dilution according to manufacturer instructions 
(Pierce Biotechnology, USA). Following incubation, immu-
nocomplexes were recovered with Protein A Sepharose 6 
MB for 2 h at 4°C and decanted by centrifugation for 20 
min at 4°C/11,000 rpm. The precipitate was washed three 
times at 5-min intervals, with a washing buffer (2 mM sodium 
orthovanadate, 100 mM Tris-HCl, 1 mM RDTA, and 0.5% 
Triton X-100). The supernatant was discarded and only the 
precipitated proteins (immunocomplexes) were retained.
ELISA for cytokine determination
Tissue levels of IL-1β, TNF-α, IL-6, and IFN-γ were deter-
mined in total protein extracts of liver and intestine (2.0 mg/
mL) using 25 µg total protein by ELISA (Pierce Biotechnol-
ogy, USA) following manufacturer recommendations. 
Determination of NF-kappaB activation
Liver and intestine NF-kappaB activation was deter-
mined in nuclear extracts by ELISA (Pierce Biotechnology, 
USA) according to manufacturer recommendations and 
using the positive and negative controls supplied.
Immunohistochemical procedures
Immunohistochemistry was performed using liver 
specimens from four fetuses. Six-micrometer cryostat sec-
tions were prepared from frozen liver, transferred to slides 
coated with poly-L-lysine and fixed in methanol for 10 min. 
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The sections were washed twice in 0.01 M phosphate-
buffered saline (PBS), pH 7.4, and endogenous peroxidase 
was eliminated by exposure to 0.03% hydrogen peroxide 
(v/v) in methanol for 5 min at room temperature. Sections 
were washed in PBS followed by incubation in PBS with 
1% bovine serum albumin (BSA, w/v) for 30 min to block 
nonspecific background. Upon BSA removal, the sections 
were treated with mouse anti-rat CD68 (ED1) and CD163 
(ED2; Serotec, USA) at a 1:50 dilution in PBS/BSA overnight 
at 4°C. After washing in PBS, slides were covered with a 
1:200 dilution of biotinylated horse anti-mouse IgG (Vector 
Laboratories, USA) in PBS, as the second antibody for 45 
min. The sections were subsequently washed in PBS and 
incubated for 30 min with streptoABC complex/HRP (Dako, 
Denmark) prepared according to manufacturer instructions. 
After washing in 10 mM Tris-buffered saline (TBS), pH 7.6, 
the antigen was visualized in tissue by staining for peroxi-
dase activity with 3,3’-diaminobenzidine-tetra-hydrochloride 
(DAB, Sigma, USA) in TBS, pH 7.6, containing H2O2, and 
rinsing in distilled water. The sections were lightly coun-
terstained with Ehrlich’s hematoxylin, rinsed in distilled 
water, dehydrated, and mounted with a permanent 
mounting medium. Negative immunohistochemistry 
controls were treated in the same way, omitting the 
primary antibody. After staining, the slides were ex-
amined by two different pathologists who counted the 
number of ED1 and ED2 hepatic cells.
Statistical analysis
Data are reported as means ± SD and were 
analyzed statistically by ANOVA using the Statistical 
Analysis System for Windows (SAS 8.01, SAS Insti-
tute Corporation 1999-2000, USA), with the level of 
significance set at 5% (P < 0.05). 
Results
Morphometric evaluation of liver and intestine
The intestine and liver measurements are pre-
sented in Table 1. The liver of control fetuses was 
lighter compared to gastroschisis fetuses and the LW/
BW relationship was lower in control fetuses compared 
to both gastroschisis and sham fetuses. The intestine 
was heavier and shorter in gastroschisis compared 
to control and sham fetuses and the IW/IL and IW/
BW ratios were higher in gastroschisis fetuses (P < 
0.05).
We then correlated IL and LW in the various 
groups using the Pearson’s correlation coefficient (r = 
Pearson’s coefficient), with the following results: gas-
troschisis (r = 0.518, P = 0.019), control (r = 0.071, P 
= 0.766) and sham (r = 0.017, P = 0.942). This shows 
that there is a statistical relationship between intestine 
length and liver weight in gastroschisis but not in control 
or sham fetuses (Figure 1). For the gastroschisis group, 
the linear least squares regression model was adjusted for 
analysis and the following estimated equation of intestine 
length based on liver weight was obtained: intestine length 
= 57.53 + 195.22 x liver weight (R2 = 26.8%; Sxy = 23.86; 
CV = 19.1%; P = 0.0193) (Figure 1).
Determination of cytokine expression in liver and 
intestine
There were decreased levels of IL-1β and TNF-α in the 
liver of gastroschisis fetuses. No significant differences in 
the amounts of IL-1β, TNF-α, IL-6, or IFN-γ were found in 
the intestine (Table 2).
Determination of NF-kappaB concentration in liver and 
intestine. There was a 4- and 2-fold increase in NF-kappaB con-
centration in the liver and intestine, respectively (Table 3).
 Determination of macrophage activation in the liver. 
Since an increase in NF-kappaB was detected in the liver, 
we investigated the presence of activated macrophages 
in this tissue with an immunohistochemical assay using 
Figure 1. Correlation between liver weight and intestinal length at 18.5 
days of gestation in rats with gastroschisis.
Table 1. Morphometric data for a rat model of gastroschisis.
Gastroschisis Control Sham
Body weight (BW, g) 5.29 ± 0.69* 5.67 ± 0.56 5.87 ± 0.49
Liver weight (LW, g) 0.36 ± 0.07 0.33 ± 0.04+ 0.38 ± 0.06
Intestine weight (IW, g) 0.29 ± 0.05*# 0.24 ± 0.04 0.23 ± 0.034
Intestine length (IL, mm) 125 ± 25.0*# 216 ± 13.9 209 ± 15.9
LW/BW (%) 6.7 ± 0.1# 5.8 ± 0.7+ 6.3 ± 0.9
IW/BW (%) 5.5 ± 1.0*# 4.1 ± 0.6 4.0 ± 0.8
IW/IL (mg/mm) 2.42 ± 0.46*# 1.09 ± 0.19 1.11 ± 0.24
Data are reported as means ± SD for 24 rats in each group. *P < 0.05, 
gastroschisis vs sham; +P < 0.05, control vs sham; #P < 0.05, gastro-
schisis vs control (ANOVA with the Tukey-Kramer post-test). 
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anti-ED1 and anti-ED2 antibodies. The average number 
of cells stained for ED1 was 18 ± 5 in gastroschisis, 16 ± 
6 in control and 19 ± 9 in sham fetuses. The numbers of 
cells stained for ED2 were 16 ± 3 in gastroschisis, 16 ± 7 
in control and 12 ± 3 in sham fetuses. There were no sig-
nificant differences among groups. Therefore, although we 
observed an increase in NF-kappaB in the liver of fetuses 
with gastroschisis this increase was not able to activate 
macrophages. 
Discussion
The survival rate of neonates with gastroschisis has 
increased in the last decades. Intestinal damage is still re-
sponsible for the increased morbidity and eventual mortality 
of these patients. The factors that contribute to morbidity 
and mortality include prematurity, low birth weight and 
gastrointestinal complications such as atresia, stenosis, 
necrotizing enterocolitis, and intestinal hypomotility derived 
from prolonged exposure of the intestine to components of 
the amniotic fluid (16,17).
The inflammatory process in gastroschisis starts in the 
uterus. Macroscopically, the exposed intestine is found to be 
thickened, shortened and coated with a fibrin layer (4,18,19). 
The intestine presents functional alterations such as loss 
of contractility, decreased enzymatic activity of the villi, and 
changes in collagen synthesis in the submucosal region (5). 
There are also alterations in the distal mesenteric vascular 
system (vasa recta), with a larger number and density of 
these small vessels.
We observed that the intestine of gastroschisis fetuses 
had an increased weight and decreased length, probably 
due to the intestinal edema resulting from exposure to 
amniotic fluid. Consequently, the IW/IL and IW/BW ratios 
were also significantly increased in gastroschisis.
On the other hand, in the experimental model of rat 
fetuses with intrauterine growth restriction, the liver weight 
is decreased (20). We have previously demonstrated in-
trauterine growth restriction in gastroschisis fetuses (21) 
but we did not correlate it with liver weight. In the present 
study, we observed that control fetuses were heavier than 
gastroschisis fetuses, but there was no difference between 
sham fetuses and gastroschisis or control fetuses. In addi-
tion, although the liver is proportionally larger in gastroschisis 
fetuses when adjusted to body weight (LW/BW), this differ-
ence was detected between gastroschisis versus controls 
(P < 0.05), but not between gastroschisis versus sham 
fetuses. This might be due to the fact that just the surgical 
stress of opening the amniotic cavity and manipulating the 
fetus without exposing their bowel to the amniotic cavity can 
affect the LW/BW ratio, so that the difference observed in 
gastroschisis fetuses might be attributed to surgical stress 
and not to gastroschisis. 
Of particular interest is the finding that the correlation 
between liver weight and intestinal length was only observed 
in gastroschisis. We may speculate that perhaps, since 
inflammation shortens the intestine, the degree of the in-
flammatory response might be inversely related to intestinal 
length and thus, the greater the inflammatory response, the 
shorter the intestine and the lighter the liver. 
To assess the degree of inflammatory reaction we in-
vestigated cytokine levels. Proinflammatory cytokines such 
as TNF-α and IL-1 are the main stimuli for the secretion 
of chemokines such as IL-6 and are detected during the 
acute phase of inflammation. Later, IL-6 down-regulates 
the production of TNF-α and IL-1 (22). During the gestation 
of human fetuses with gastroschisis a subchronic pattern 
of interleukins has been reported in the amniotic fluid with 
an increase of IL-6 and IL-8 (10). In the present study, the 
perinatal levels of TNF-α and IFN-γ were normal in the 
intestine and there was a decrease of TNF-α and IL-1β in 
the liver of the fetuses with gastroschisis. This decrease 
could be due to a later stage of the inflammatory process 
during the perinatal period.
Intestinal inflammation has also been associated with 
the increase of NF-kappaB, which has been demonstrated 
to play a key role both in inflammatory bowel disease and 
gastroschisis (23-26). We also found elevation of NF-
kappaB levels both in the intestine and liver of fetuses with 
gastroschisis (P < 0.05). These results show that there was 
activation of the inflammatory cascade both in the intestine 
Table 2. IL, TNF-α and IFN-γ levels in the intestine of a rat model 
of gastroschisis.
Gastroschisis Control Sham
IL-1β 49 ± 4.0 71.5 ± 27.1 52.2 ± 13
IL-6 166.5 ± 1.1 190.5 ± 10.7 186.8 ± 15.9
IL-10 28 ± 5.2 24.6 ± 1.3 28.8 ± 0.3
TNF-α 0.11 ± 0.04 0.19 ± 0.03 0.16 ± 0.04
IFN-γ 5.6 ± 0.9 7.9 ± 2.0 5.6 ± 1.5
Data are reported as means ± SD in pg/2 mg intestine homoge-
nate protein for 4 rats in each group. There were no statistical 
differences among groups (ANOVA with the Tukey post-test).
Table 3. Levels of NF-kappaB in the liver and intestine of a rat 
model of gastroschisis.
Gastroschisis Control Sham
Liver (g) 0.105 ± 0.03*+ 0.025 ± 0.018 0.021 ± 0.033
Intestine (g) 0.021 ± 0.002*+ 0.014 ± 0.006 0.013 ± 0.009
Data are reported as means ± SD in pg/2 mg liver homogenate 
protein for 5 rats in each group. *P < 0.05, gastroschisis vs con-
trol; +P < 0.05, gastroschisis vs sham (ANOVA with the Tukey-
post-test).
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and in the liver, suggesting that the inflammatory response 
in gastroschisis is activated in both organs.
The increase of NF-kappaB has been associated with 
an increased number of circulating and tissue histiocytes 
(ED1 and ED2) (13). However, in the gastroschisis model, 
we did not observe this phenomenon. Although the in-
flammation of the intestine might have been sufficient to 
increase NF-kappaB levels in both the intestine and the 
liver, it might not have been strong enough to increase the 
number of histiocytes, due to the lack of infectious stimuli 
of inflammation. 
Finally, we observed that the inflammatory cascade 
activation expressed by an increase of NF-kB levels exists 
in the intestine and mainly in the liver of rats with experi-
mental gastroschisis represented by an observed decrease 
of IL-1β and TNF-α. These data support the theory that the 
intestine-liver axis has a role in the inflammatory process 
of experimental gastroschisis. Moreover, shorter bowel 
loops accompany smaller livers. The implications of the 
hepatic inflammatory process activated in gastroschisis 
may stimulate new studies of the prognosis and treatment 
of fetal gastroschisis, as well as studies of responses to 
the fetal insulin receptors in the presence of in utero inflam-
matory processes and growth retardation in gastroschisis 
(27,28).
To our knowledge, this is the first study demonstrating 
activation of the inflammatory response in the liver of the rat 
model of gastroschisis. Further investigations are needed 
to elucidate other inflammatory pathways involved and 
their consequences.
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